Welcome to our dedicated page for TERADYNE SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TERADYNE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TERADYNE's regulatory disclosures and financial reporting.
Teradyne director Mercedes Johnson reported an open-market stock sale. On the stated date, Johnson sold 625 shares of Teradyne common stock at a price of $299.20 per share under a pre-arranged Rule 10b5-1 trading plan adopted on February 3, 2025.
After this transaction, Johnson directly owned 6,988 shares of common stock. An additional 1,876 shares were held indirectly by The Mercedes Johnson Trust UAD 07/23/04, for which Johnson is trustee and sole beneficiary.
TER notice: a Form 144 reports a proposed sale of common stock by Mercedes Johnson.
The filing lists recent sales by Mercedes Johnson including 12/05/2025 for $125,000.00, 01/05/2026 for $132,406.25, and 02/05/2026 for $166,862.50. The record shows Restricted Stock Vesting dated 05/10/2016 and references Fidelity Brokerage Services LLC and NASDAQ.
Teradyne, Inc. reported an insider stock sale by executive Mills Regan. Regan, who serves as President, Product Test, sold 788 shares of Teradyne common stock in an open-market transaction at a price of $332.87 per share on February 25, 2026. After this transaction, Regan directly owned 11,889.3452 shares of Teradyne common stock. The shares were sold under a pre-arranged Rule 10b5-1 trading plan adopted on November 25, 2025, which is designed to allow insiders to sell shares according to a preset schedule.
TER reported a series of restricted common stock vesting events. The filing lists vesting of 182, 192, 228 and 186 common shares on 01/27/2026, 01/28/2026, 01/31/2026 and 02/01/2026, respectively. The entries are labeled as Restricted Stock Vesting with the issuer shown as the source.
Teradyne, Inc. files its annual report describing a business driven by automated semiconductor test, robotics and product test systems, with demand heavily tied to AI and data center applications. The Semiconductor Test segment saw strong 2025 growth from AI-related networking and vertically integrated compute customers, while Product Test benefited from defense and aerospace demand.
Robotics returned to sequential quarterly revenue growth but faces foreign-currency headwinds because most sales are non‑U.S. dollar. Teradyne expanded through acquisitions of Quantifi Photonics for $127.2 million and Infineon’s AET unit for 17.6 million euros, and agreed to invest about $157 million for 75% of a new AI data center test joint venture. As of December 31, 2025, the company employed about 6,600 people, generated 89% of revenue outside the United States, and highlights risks from customer concentration, export controls, supply chain constraints, tariffs, cybersecurity and global economic cycles.
Teradyne, Inc. reported that President and CEO Gregory Stephen Smith received new equity awards. On February 4, 2026, he was granted 13,380 restricted stock units, each representing one share of common stock, which vest in four equal annual installments beginning on February 4, 2027.
On the same date, he was also granted a stock option for 11,810 shares of common stock at an exercise price of $269.07 per share, vesting 25% per year over four years starting on February 4, 2027. After these grants, he beneficially owned 128,469.5729 shares of common stock directly and 11,810 stock options directly.
Teradyne executive Shannon John Poulin, President, Semiconductor Test, reported new equity awards. On February 4, 2026, he received 4,460 restricted stock units of common stock at no cost, bringing his directly held common shares to 17,235.5779.
The RSUs vest in four equal annual installments beginning on February 4, 2027. He also received a stock option grant for 3,937 shares of common stock with a $269.07 exercise price, vesting 25% per year over four years starting on February 4, 2027.
Teradyne VP, General Counsel and Secretary Ryan Driscoll reported new equity awards. On February 4, 2026, he received 1,784 restricted stock units under Teradyne’s 2006 Equity and Cash Compensation Incentive Plan, each representing one share of common stock and vesting in four equal annual installments starting February 4, 2027.
He was also granted a stock option for 1,575 shares of common stock at an exercise price of $269.07 per share, vesting 25% per year over four years beginning February 4, 2027. Following the RSU grant, he beneficially owned 8,345.3054 shares of Teradyne common stock directly.
Teradyne, Inc. officer equity awards: President, Product Test Mills Regan reported new equity grants dated February 4, 2026. He received 1,004 restricted stock units (RSUs), each equal to one share of common stock, and now directly holds 12,677.3452 common shares after this grant.
The 1,004 RSUs were granted at no cash cost and will vest in four equal annual installments beginning on February 4, 2027. He was also granted a stock option for 886 shares at an exercise price of $269.07 per share, which vests 25% per year over four years starting on the same date.
Teradyne, Inc. President Teradyne Robotics Jean Pierre Hathout received new equity awards. On February 4, 2026, he was granted 1,004 shares of Common Stock in the form of restricted stock units at a grant price of $0, increasing his directly held Common Stock to 10,174 shares.
He was also granted a stock option for 886 shares of Common Stock with a $269.07 exercise price, expiring February 4, 2033. The RSUs vest in four equal annual installments beginning February 4, 2027, and the option vests 25% per year over four years starting on the same date.